Cue Biopharma CUE
NASDAQ CUE
$28.03 -2.47 (-8.10%)
As of: Sep 10, 2026 · 3:59 PM EDT

Cue Biopharma (CUE) Intangibles (2017 - 2018)

Cue Biopharma's (CUE) quarterly Intangibles came in at $175000.0 in Q3 2018, little changed quarter-over-quarter from $175000.0 in Q2 2018.

Analysis

Cue Biopharma (CUE) Intangibles (2017 - 2018) Analysis & Trends

Cue Biopharma has disclosed Intangibles across 2 years of filings, most recently posting $175000.0 for Q3 2018.

  • In Q3 2018, Intangibles changed N/A year-over-year to $175000.0; the TTM figure through Sep 2018 stood at $175000.0 (changed N/A YoY), while the FY2017 annual figure was $175000.0, changed N/A from the prior year.
  • Intangibles came in at $175000.0 for Q3 2018 at Cue Biopharma, roughly flat from $175000.0 in the prior quarter.
  • In the past five years, Intangibles ranged from a high of $175000.0 in Q4 2017 to a low of $175000.0 in Q4 2017.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Intangibles (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn 20.49 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn 14.03 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn 412.80 Mn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn 1.31 Bn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn 266.00 Mn
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn -
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn -
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn 13.52 Bn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn -
10 Cue Biopharma 179.95 Mn 162.53 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2018 175,000.00
Jun 30, 2018 175,000.00
Mar 31, 2018 175,000.00
Dec 31, 2017 175,000.00